Pembrolizumab in Combination With Dabrafenib and Trametinib as a Neoadjuvant Strategy Prior to Surgery in BRAF-Mutated Anaplastic Thyroid Cancer. The gene discussed is BRAF; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.